Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Epstein-Barr Virus Infections × Restraint, Physical × 1 year × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 4 Prostatic Neoplasms 3 Neoplasms 3 Uterine Cervical Dysplasia 2 Sarcoma 2 Glioma 2 Glioblastoma 2 Breast Neoplasms 2 Atypical Squamous Cells of the Cervix 2 Xeroderma Pigmentosum 1 Triple Negative Breast Neoplasms 1 Trichothiodystrophy Syndromes 1 Squamous Intraepithelial Lesions 1 Spinal Cord Neoplasms 1 Pilonidal Sinus 1 Peritoneal Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neurofibroma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 HIV Infections 1

Interventions

Valganciclovir 3 Cisplatin 3 Vincristine 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Prednisone 2 Matrix-M 2 Gemcitabine 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 pomalidomide 1 dehydroftorafur 1 brincidofovir 1 Watchful Waiting 1 Valacyclovir 1 Tomography, X-Ray Computed 1 Tenofovir 1 Tegafur 1 Taxes 1 Platinum 1 Phantoms, Imaging 1 Paclitaxel 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Interferons 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡